skip to Main Content
Earn up to $600,000
in Research Grants

Open Innovation program offers research grants to perform clinical studies, for defined target
pathogens.

Applications close October 31, 2023

One Sample,
Many Answers

Seegene’s solutions offer user friendly workflows for the laboratories and comprehensive molecular PCR results that enable fact-based research. Our technology makes it possible to detect hundreds of targets on a single platform.

Infectious Diseases
High Multiplex PCR Products

Seegene provides molecular PCR products capable of detecting multiple targets simultaneously. Our high multiplex assays deliver comprehensive information using our proprietary technology that produces high multiplex results from a single channel in a PCR reaction.

Detect CT, NG, TV, MG, and more STIs with confidence

Cover all your lab’s respiratory needs

Robust detection and identification of UTI causing pathogens

Molecular solutions for GI bacteria, viruses, and parasites

Learn more about Seegene’s high multiplex real-time PCR technologies
Benefits of
Seegene’s Solution
For Technicians / Labs
  • Simultaneous detection of multiple pathogens in a single test
  • Affordable detection and identification which minimizes labor and cost
  • Provide comprehensive tests on one platform
  • Fast turnaround time of under 4 hours (includes extraction and PCR time)
  • Fewer runs for detecting pathogens of interest
Our vision
See Ahead.
Change Tomorrow.

Seegene strives to bring healthier and happier life to everyone by making molecular testing more accessible in our daily lives.

News and Events
Latest News:
SGHQ Open Innovation Program

Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature

Together, we can create a disease-free future Register for the webcast - A replay will be available for those who…

Read More
Upcoming Events:
Blog
SGHQ Open Innovation Program

Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature

Together, we can create a disease-free future Register for the webcast - A replay will be available for those who register! Click ▶ Nature Research (workcast.com) Date: Thursday, September 21,…

Read More

Laboratory-Developed Tests: A Best Practices Primer

Laboratory-developed tests (LDTs) played a critical role during the COVID-19 pandemic. In fact, many current molecular tests were developed as laboratory-developed tests, outside the strict regulatory framework of the U.S.…

Read More

Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.

Company expands presence and support in US market. Proprietary TOCE™ technology overcomes PCR testing limitations for high multiplex applications. IRVINE, Calif., January 5, 2023 (Newswire.com) - Seegene Technologies, Inc., a subsidiary…

Read More
Back To Top